Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Intangibles (2023 - 2025)

Historic Intangibles for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $120000.0.

  • Tonix Pharmaceuticals Holding's Intangibles changed 0.0% to $120000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $120000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $120000.0 for FY2024, which is 9876.83% down from last year.
  • According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Intangibles is $120000.0, which was down 0.0% from $120000.0 recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's Intangibles' 5-year high stood at $10.2 million during Q2 2023, with a 5-year trough of $120000.0 in Q2 2024.
  • In the last 3 years, Tonix Pharmaceuticals Holding's Intangibles had a median value of $120000.0 in 2024 and averaged $4.0 million.
  • As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Intangibles tumbled by 9882.58% in 2024, and later changed by 0.0% in 2025.
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Intangibles stood at $9.7 million in 2023, then plummeted by 98.77% to $120000.0 in 2024, then changed by 0.0% to $120000.0 in 2025.
  • Its Intangibles was $120000.0 in Q3 2025, compared to $120000.0 in Q2 2025 and $120000.0 in Q1 2025.